ArticleScientific reports2022

Concomitant KRAS mutations attenuate sensitivity of non-small cell lung cancer cells to KRAS G12C inhibition.

Tereza Vaclova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.